Bio-Rad Laboratories Inc. (BIO)
Market Closed
16 Oct, 08:00 PM
$
353. 70
-11.12
-3.0481%
$
9.46B Market Cap
- P/E Ratio
- Div Yield
207,700 Volume
11.51 Eps
$ 364.82
Previous Close 
Want to track BIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bio-Rad Laboratories Inc. (BIO) Statistics
Valuation metrics
Market Cap 9.46B
Enterprise value 10.54B
Trailing P/E (ttm) 43.96
Forward P/E 24.99
PEG ratio -0.15
Price/Sales (ttm) 3.81
Price/Book (mrq) 1.37
Enterprise Value/Revenue 4.07
Enterprise Value/EBITDA 20.48
Overview
Shares outstanding 26.83M
Float 20.9M
Shares short 34
% Held by insiders 0.16%
% Held by institutions 0.9%
Average volume (10 days) 139K
Average volume (90 days) 281.73K
Price summary
52-Week low 236.73
52-Week high 396.23
Beta 1.06
50-Day moving average 377.89
200-Day moving average 292.5
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0.22
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 8 Mar 2002
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.09%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.03%
Income Statement
Revenue (ttm) 2.59B
Revenue per share (ttm) 96.81
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 1.35B
EBITDA 478.9M
Net income to common (ttm) 168.8M
Diluted EPS (ttm) 8.32
Quarterly earnings growth (yoy) 0.01%
Balance Sheet
Total cash (mrq) 1.56B
Total cash per share (mrq) 60.51
Total debt (mrq) 1.38B
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 3.14%
Book value per share (mrq) 268.22
Cash Flow
Cash flow statement 510.4M
Levered free cash flow (LFCF) 229.76M
2026 © Marketlog. All Rights Reserved.
